Inventiva S.A. business relationships
Companies named in Inventiva S.A.’s 20-F filed 2026-04-08, and public companies whose annual reports name Inventiva S.A.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.2 / 10
- AI naming
- 46 / 100 Top 1% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Inventiva S.A.’s annual report 2
“For example, we previously entered into a partnership with AbbVie for the development of cedirogant, which ended in October 2022 when AbbVie decided to stop the development of cedirogant following the analysis of a nonclinical toxicology study.” SEC filing
“Concentrations of credit risk are with respect to trade receivables owed by a limited number of licensees, including Hepalys and CTTQ.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.